Zum Hauptinhalt springen

Naltrexon

14. Oktober 2025 | Naltrexon

Evaluating Treatment Options for Opiate Use Disorder: A Meta-Analysis of Buprenorphine-Naloxone and Extended-Release Naltrexone.

Evaluating Treatment Options for Opiate Use Disorder: A Meta-Analysis of Buprenorphine-Naloxone and Extended-Release Naltrexone. Awaji BH, Abanmi SN, Alqahtani MS, Alhodathi L, Alrehaili M, Aldohan TF, Alkhenaizan AS, Alsughayer ZM, Alyahya A…

14. Oktober 2025 | Naltrexon

Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder.

Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder. Brier LM, Langleben DD, Wiers CE, Shi Z. bioRxiv [Preprint]. 2025 Sep 19:2025.09.18.676931. doi: 10.1101/2025.09.18.67693…

29. September 2025 | Naltrexon

Fentanyl-blocking effects of extended-release naltrexone in humans: Three case reports.

Fentanyl-blocking effects of extended-release naltrexone in humans: Three case reports. Brewer C. J Opioid Manag. 2025 Jul-Aug;21(4):355-359. doi: 10.5055/jom.0949. PMID: 40910985. Abstract https://wmpllc.org/ojs/index.php/jom/articl…

05. Juli 2025 | Naltrexon

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. Mordal J, Juya F, Holtan L, Vederhus JK, Opheim A, Brenna IH, Enger AE, Weimand B, Solli KK, Tanum L.&n…

05. Juli 2025 | Naltrexon

Comparison of Naltrexone Implant and Oral Buprenorphine Naloxone in The Treatment of Opioid Use Disorder: A Retrospective Cohort Study.

Comparison of Naltrexone Implant and Oral Buprenorphine Naloxone in The Treatment of Opioid Use Disorder: A Retrospective Cohort Study. Peker O, Peker İ, Çayköylü A. Noro Psikiyatr Ars. 2024 Aug 9;62(2):125-130. doi: 10.29399/npa.28738…

05. Juli 2025 | Naltrexon

Explaining increased efficacy of naltrexone in the treatment of alcohol dependent patients with a family history of alcohol use disorder: A systematic review on the role of reward sensitivity and sweet liking.

Explaining increased efficacy of naltrexone in the treatment of alcohol dependent patients with a family history of alcohol use disorder: A systematic review on the role of reward sensitivity and sweet liking. van Amsterdam J, van den Brink W…

07. Juni 2025 | Naltrexon

Sustained-release naltrexone for opioid dependence.

Sustained-release naltrexone for opioid dependence. Kornør H, Lobmaier PPK, Kunøe N. Cochrane Database Syst Rev. 2025 May 9;5(5):CD006140. doi: 10.1002/14651858.CD006140.pub3. PMID: 40342086; PMCID: PMC12063202. Abstract https://www…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten